Cargando…
Suppressor T cells activated in a primary in vitro response to non- major histocompatibility alloantigens
Normal mouse spleen cells are not capable of mounting a primary cytotoxic T lymphocyte (Tc) response to non-H-2 alloantigens in vitro, although a good secondary H-2-restricted response is observable after in vivo immunization of the responder animals. Suppressor cells are generated in such a primary...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186850/ https://www.ncbi.nlm.nih.gov/pubmed/6215457 |
_version_ | 1782146037511618560 |
---|---|
collection | PubMed |
description | Normal mouse spleen cells are not capable of mounting a primary cytotoxic T lymphocyte (Tc) response to non-H-2 alloantigens in vitro, although a good secondary H-2-restricted response is observable after in vivo immunization of the responder animals. Suppressor cells are generated in such a primary responses provided a Mls incompatibility exists between the responder and stimulator. These suppressors are not antigen specific, are Thy-1+, Lyt-1+, 2-, I-J-, and are highly radiosensitive. The suppressor cell precursors in normal spleen express the same phenotype. These suppressor cells are probably implicated in the lack of a primary Tc response in a primary mixed lymphocyte reaction across non-H-2 incompatibilities that include an Mls difference. |
format | Text |
id | pubmed-2186850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1982 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21868502008-04-17 Suppressor T cells activated in a primary in vitro response to non- major histocompatibility alloantigens J Exp Med Articles Normal mouse spleen cells are not capable of mounting a primary cytotoxic T lymphocyte (Tc) response to non-H-2 alloantigens in vitro, although a good secondary H-2-restricted response is observable after in vivo immunization of the responder animals. Suppressor cells are generated in such a primary responses provided a Mls incompatibility exists between the responder and stimulator. These suppressors are not antigen specific, are Thy-1+, Lyt-1+, 2-, I-J-, and are highly radiosensitive. The suppressor cell precursors in normal spleen express the same phenotype. These suppressor cells are probably implicated in the lack of a primary Tc response in a primary mixed lymphocyte reaction across non-H-2 incompatibilities that include an Mls difference. The Rockefeller University Press 1982-11-01 /pmc/articles/PMC2186850/ /pubmed/6215457 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Suppressor T cells activated in a primary in vitro response to non- major histocompatibility alloantigens |
title | Suppressor T cells activated in a primary in vitro response to non- major histocompatibility alloantigens |
title_full | Suppressor T cells activated in a primary in vitro response to non- major histocompatibility alloantigens |
title_fullStr | Suppressor T cells activated in a primary in vitro response to non- major histocompatibility alloantigens |
title_full_unstemmed | Suppressor T cells activated in a primary in vitro response to non- major histocompatibility alloantigens |
title_short | Suppressor T cells activated in a primary in vitro response to non- major histocompatibility alloantigens |
title_sort | suppressor t cells activated in a primary in vitro response to non- major histocompatibility alloantigens |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186850/ https://www.ncbi.nlm.nih.gov/pubmed/6215457 |